Effect of different durations of treatment with antihypertensive drugs with anticholinergic effects on the risk of dementia: a target trial emulation study
American Journal of Epidemiology · 04.03.2025 · 194 (3) · 691-698
DOI: 10.1093/aje/kwae263 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Epidemiology, online erschienen am 06.08.2024. Verfasst von Jaume Aguado und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain. Hauptthemen laut MEDLINE: Antihypertensive Agents, Cholinergic Antagonists, Alzheimer Disease, Dementia, Vascular. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Professional Development Award.
Themen: Demenz
Abstract (Originalsprache)
Studying the effect of duration of treatment on prognostic outcomes using real-world data is challenging because only people who survive for a long time can receive a treatment for a long time. Specifying a target trial helps overcome such challenge. We aimed to estimate the effect of different durations of treatment with antihypertensive drugs with anticholinergic properties (AC AHT) on the risk of vascular dementia and Alzheimer’s disease by emulating a target trial using the UK CPRD GOLD database (2001-2017). Comparing treatment for 3-6 years vs ≤3 years yielded null results for both types of dementia. Comparing a longer duration of treatment, >6 years vs ≤3 years, yielded a 10-year risk ratio of 0.69 (95% CI, 0.54-0.90) for vascular dementia and 0.91 (95% CI, 0.77-1.10) for Alzheimer’s disease. For illustration, we performed an analysis that failed to emulate a target trial by assigning exposure categories using postbaseline information, obtaining implausible beneficial estimates. Our findings indicate a modest benefit of longer duration of treatment with AC AHT on vascular dementia and highlight the value of the target trial emulation to avoid selection bias in the evaluation of the effect of different durations of treatment. This article is part of a Special Collection on Pharmacoepidemiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain.
- Pharmacoepidemiology and Risk Management, RTI Health Solutions, Waltham, MA, United States.
ORCID-Profile: Jaume Aguado, Lia Gutierrez, Joan Forns, Julia Vila-Guilera, Kenneth J Rothman, Xabier García-Albéniz
Förderung
- Professional Development Award
Zitieren
APA
Aguado, J., Gutierrez, L., Forns, J., Vila-Guilera, J., Rothman, K. J., & García-Albéniz, X. (2025). Effect of different durations of treatment with antihypertensive drugs with anticholinergic effects on the risk of dementia: a target trial emulation study. American Journal of Epidemiology, 194(3), 691-698. https://doi.org/10.1093/aje/kwae263
Vancouver
Aguado J, Gutierrez L, Forns J, Vila-Guilera J, Rothman KJ, García-Albéniz X. Effect of different durations of treatment with antihypertensive drugs with anticholinergic effects on the risk of dementia: a target trial emulation study. American Journal of Epidemiology. 2025;194(3):691-698. doi:10.1093/aje/kwae263
BibTeX
@article{Aguado2025,
author = {Aguado, Jaume and Gutierrez, Lia and Forns, Joan and Vila-Guilera, Julia and Rothman, Kenneth J and García-Albéniz, Xabier},
title = {Effect of different durations of treatment with antihypertensive drugs with anticholinergic effects on the risk of dementia: a target trial emulation study},
journal = {American Journal of Epidemiology},
year = {2025},
volume = {194},
number = {3},
pages = {691--698},
doi = {10.1093/aje/kwae263}
}
EUVIMED